Product Code: ETC4441802 | Publication Date: Jul 2023 | Updated Date: Aug 2025 | Product Type: Report | |
Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 |
The United States Exoskeleton Market is experiencing steady growth driven by increasing adoption in healthcare, military, and industrial sectors. The healthcare industry is a significant contributor to market growth, with exoskeletons being used for rehabilitation and mobility assistance purposes. Additionally, the military sector is investing in exoskeleton technology for enhancing soldiers` strength and endurance in combat situations. The industrial sector is also adopting exoskeletons to improve worker safety and productivity. Key players in the US exoskeleton market include Ekso Bionics, ReWalk Robotics, and Lockheed Martin. Technological advancements in materials and sensors are driving innovation in exoskeleton design, making them more lightweight, comfortable, and user-friendly. The market is expected to continue its growth trajectory as more industries recognize the benefits of exoskeleton technology.
The United States Exoskeleton Market is experiencing significant growth driven by advancements in technology, increased adoption in various industries such as healthcare, manufacturing, and defense, and rising demand for ergonomic solutions. Companies are focusing on developing lightweight, user-friendly exoskeletons with enhanced safety features to cater to a diverse range of applications. The healthcare sector, in particular, presents a lucrative opportunity for exoskeleton manufacturers due to the growing aging population and the need for rehabilitation and assistive devices. Additionally, the military and defense sector is investing in exoskeleton technology to enhance soldier performance and reduce the risk of injuries. Overall, the US Exoskeleton Market is poised for expansion as awareness about the benefits of exoskeletons continues to grow across different sectors.
In the US Exoskeleton Market, several challenges are being faced. One major challenge is the high cost associated with exoskeleton technology, making it inaccessible to many potential users due to affordability constraints. Additionally, there are regulatory barriers and a lack of standardized guidelines for the use of exoskeletons in different industries, leading to uncertainty and slower adoption rates. Another challenge is the limited awareness and understanding of the benefits of exoskeletons among potential users, which hinders the market growth. Furthermore, the current technological limitations such as battery life, weight, and mobility restrictions also pose challenges in making exoskeletons more practical and widely accepted in various sectors. Overcoming these challenges will be crucial for the US Exoskeleton Market to realize its full potential and achieve widespread adoption.
The United States Exoskeleton Market is primarily driven by factors such as the increasing adoption of exoskeletons in industries such as healthcare, military, and construction to enhance worker safety and productivity. The growing prevalence of musculoskeletal disorders among the aging population and the need for rehabilitation solutions also contribute to market growth. Technological advancements leading to more lightweight, comfortable, and affordable exoskeletons are further fueling market demand. Additionally, government support in the form of funding for research and development, as well as initiatives to promote the use of exoskeletons in healthcare and defense sectors, are key drivers shaping the growth trajectory of the US Exoskeleton Market.
The US government has several policies that impact the exoskeleton market. The Department of Veterans Affairs (VA) provides funding for exoskeleton technology to assist veterans with mobility impairments. Additionally, the Food and Drug Administration (FDA) regulates exoskeletons as medical devices, ensuring their safety and effectiveness. The National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) supports research and development in the field of exoskeleton technology to enhance accessibility and independence for individuals with disabilities. These government policies play a crucial role in advancing the US exoskeleton market by promoting innovation, ensuring quality standards, and providing financial support for users in need.
The future outlook for the United States Exoskeleton Market appears promising, with significant growth potential driven by advancements in technology, increasing adoption across various industries such as healthcare, military, and manufacturing, and rising awareness about the benefits of exoskeletons in enhancing human performance and reducing physical strain. The market is expected to witness a surge in demand for exoskeletons for medical rehabilitation purposes, as well as for augmenting physical abilities in industrial and defense applications. Key factors such as ongoing research and development initiatives, collaborations between technology companies and healthcare providers, and favorable government regulations supporting the use of exoskeletons are likely to propel market expansion in the coming years, offering lucrative opportunities for industry players and investors.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Exoskeleton Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Exoskeleton Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Exoskeleton Market - Industry Life Cycle |
3.4 United States (US) Exoskeleton Market - Porter's Five Forces |
3.5 United States (US) Exoskeleton Market Revenues & Volume Share, By Component , 2021 & 2031F |
3.6 United States (US) Exoskeleton Market Revenues & Volume Share, By Type , 2021 & 2031F |
3.7 United States (US) Exoskeleton Market Revenues & Volume Share, By Body Part, 2021 & 2031F |
3.8 United States (US) Exoskeleton Market Revenues & Volume Share, By Mobility, 2021 & 2031F |
3.9 United States (US) Exoskeleton Market Revenues & Volume Share, By Structure, 2021 & 2031F |
3.10 United States (US) Exoskeleton Market Revenues & Volume Share, By Vertical, 2021 & 2031F |
4 United States (US) Exoskeleton Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of disabilities and chronic conditions in the US population |
4.2.2 Technological advancements in exoskeletons leading to improved functionality and affordability |
4.2.3 Growing adoption of exoskeletons in rehabilitation and medical settings |
4.3 Market Restraints |
4.3.1 High initial costs associated with exoskeleton technology |
4.3.2 Limited reimbursement policies for exoskeletons in healthcare systems |
4.3.3 Regulatory challenges and safety concerns impacting market growth |
5 United States (US) Exoskeleton Market Trends |
6 United States (US) Exoskeleton Market, By Types |
6.1 United States (US) Exoskeleton Market, By Component |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Exoskeleton Market Revenues & Volume, By Component , 2021 - 2031F |
6.1.3 United States (US) Exoskeleton Market Revenues & Volume, By Hardware, 2021 - 2031F |
6.1.4 United States (US) Exoskeleton Market Revenues & Volume, By Software, 2021 - 2031F |
6.2 United States (US) Exoskeleton Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Exoskeleton Market Revenues & Volume, By Powered, 2021 - 2031F |
6.2.3 United States (US) Exoskeleton Market Revenues & Volume, By Passive, 2021 - 2031F |
6.3 United States (US) Exoskeleton Market, By Body Part |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Exoskeleton Market Revenues & Volume, By Lower Extremities, 2021 - 2031F |
6.3.3 United States (US) Exoskeleton Market Revenues & Volume, By Upper Extremities, 2021 - 2031F |
6.3.4 United States (US) Exoskeleton Market Revenues & Volume, By Full Body, 2021 - 2031F |
6.4 United States (US) Exoskeleton Market, By Mobility |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Exoskeleton Market Revenues & Volume, By Stationary, 2021 - 2031F |
6.4.3 United States (US) Exoskeleton Market Revenues & Volume, By Mobile, 2021 - 2031F |
6.5 United States (US) Exoskeleton Market, By Structure |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Exoskeleton Market Revenues & Volume, By Rigid Exoskeletons, 2021 - 2031F |
6.5.3 United States (US) Exoskeleton Market Revenues & Volume, By Soft Exoskeletons, 2021 - 2031F |
6.6 United States (US) Exoskeleton Market, By Vertical |
6.6.1 Overview and Analysis |
6.6.2 United States (US) Exoskeleton Market Revenues & Volume, By Healthcare, 2021 - 2031F |
6.6.3 United States (US) Exoskeleton Market Revenues & Volume, By Defense, 2021 - 2031F |
6.6.4 United States (US) Exoskeleton Market Revenues & Volume, By Industrial, 2021 - 2031F |
6.6.5 United States (US) Exoskeleton Market Revenues & Volume, By Others, 2021 - 2031F |
7 United States (US) Exoskeleton Market Import-Export Trade Statistics |
7.1 United States (US) Exoskeleton Market Export to Major Countries |
7.2 United States (US) Exoskeleton Market Imports from Major Countries |
8 United States (US) Exoskeleton Market Key Performance Indicators |
8.1 Number of clinical trials and research studies on exoskeleton technology in the US |
8.2 Percentage of healthcare facilities offering exoskeleton therapy programs |
8.3 Adoption rate of exoskeletons in non-medical applications, such as industrial and military sectors |
9 United States (US) Exoskeleton Market - Opportunity Assessment |
9.1 United States (US) Exoskeleton Market Opportunity Assessment, By Component , 2021 & 2031F |
9.2 United States (US) Exoskeleton Market Opportunity Assessment, By Type , 2021 & 2031F |
9.3 United States (US) Exoskeleton Market Opportunity Assessment, By Body Part, 2021 & 2031F |
9.4 United States (US) Exoskeleton Market Opportunity Assessment, By Mobility, 2021 & 2031F |
9.5 United States (US) Exoskeleton Market Opportunity Assessment, By Structure, 2021 & 2031F |
9.6 United States (US) Exoskeleton Market Opportunity Assessment, By Vertical, 2021 & 2031F |
10 United States (US) Exoskeleton Market - Competitive Landscape |
10.1 United States (US) Exoskeleton Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Exoskeleton Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |